Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
Robert Bonakdar MD, FAAFP, FACN
Robert Bonakdar MD, FAAFP, FACN Advisory Board
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
See All Experts
featured
Published in Primary Care

Journal Scan / Consensus and Guidelines · December 12, 2019

New Pneumococcal Vaccine Recommendations in Adults ≥65 Years

MMWR. Morbidity and Mortality Weekly Report

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Jonathan Temte MD, PhD

MMWR. Morbidity and Mortality Weekly Report
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR Morb. Mortal. Wkly. Rep. 2019 Nov 22;68(46)1069-1075, A Matanock, G Lee, R Gierke, M Kobayashi, A Leidner, T Pilishvili

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated